Medication info
Prastan Tablets 40 mg (Pravastatin Sodium)

Prastan Tablets 40 mg (Pravastatin Sodium)

Prescription medicationTabletOral
Ingredient · strength
Pravastatin Sodium›40mg / 1 tablet
Manufacturer / importer
Youngjin Pharmaceutical Co., Ltd.
Appearance
It is a reddish-brown oblong tablet.
Packaging
100 tablets/PTP (10 tablets/PTP*10), 300 tablets/bottle
Approval status
Active

MFDS item code 200300660 · Notified 2003.09.09 · Insurance code 642401690

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular and cerebrovascular diseases (myocardial infarction, ischemic stroke, etc.)
Who takes it
Adults
Adult dose
The usual starting dose is 10㎎, 20㎎, or 40㎎ as a single dose once daily. The dose may be increased to a maximum of 40㎎ depending on the patient's response. The maintenance dose is 10∼40㎎ once daily. 1) In patients with a history of myocardial infarction or unstable angina, the treatment goal of reducing the risk of myocardial infarction, the need for cardiovascular revascularization, ischemic stroke, and transient ischemic attack can be achieved with pravastatin sodium 40㎎/day. The efficacy of lower doses has not been studied. 2) Patients receiving immunosuppressants such as cyclosporine: The initial dose is 5∼10mg, and great caution should be exercised when increasing the dose. The maximum daily dose is 20mg. However, in kidney transplant recipients, the dose should not exceed 10mg per day.

Ingredients

Manufacturer
Youngjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular and cerebrovascular diseases (myocardial infarction, ischemic stroke, etc.)

  • Primary hyperlipidemia
  • hypercholesterolemia
  • hypertriglyceridemia
  • history of vascular disease
  • slight changes in resting ECG
  • diabetes
  • smoking
  • decreased HDL levels
  • family history of myocardial infarction
  • hypertension
  • history of myocardial infarction
  • history of unstable angina.
View approved original text

This medication is used to treat primary hyperlipidemia, particularly hypercholesterolemia (type IIa) and mixed hyperlipidemia (type IIb) with both hypercholesterolemia and hypertriglyceridemia. It also helps reduce the risk of myocardial infarction and mortality from coronary heart disease in high-risk patients with hypercholesterolemia or mixed hyperlipidemia. This high-risk group includes males aged between 45 to 65 with various risk factors such as a history of vascular disease, diabetes, and smoking. Furthermore, it is effective in reducing the risk of myocardial infarction recurrence, the need for cardiovascular revascularization, ischemic stroke, and transient ischemic attack in patients with a history of myocardial infarction or unstable angina. In summary, this drug reduces cardiovascular risk associated with hyperlipidemia and is used in the treatment of cardiovascular diseases.

How to take

Adult dose

The usual starting dose is 10㎎, 20㎎, or 40㎎ as a single dose once daily. The dose may be increased to a maximum of 40㎎ depending on the patient's response. The maintenance dose is 10∼40㎎ once daily. 1) In patients with a history of myocardial infarction or unstable angina, the treatment goal of reducing the risk of myocardial infarction, the need for cardiovascular revascularization, ischemic stroke, and transient ischemic attack can be achieved with pravastatin sodium 40㎎/day. The efficacy of lower doses has not been studied. 2) Patients receiving immunosuppressants such as cyclosporine: The initial dose is 5∼10mg, and great caution should be exercised when increasing the dose. The maximum daily dose is 20mg. However, in kidney transplant recipients, the dose should not exceed 10mg per day.

Precautions

This drug should not be used in certain patients. For example, it should not be administered to patients who are allergic to this drug, those with severe liver disease, pregnant women or females who may become pregnant, nursing women, children, patients with severe liver or kidney dysfunction, patients with muscle disorders, or patients with issues in bile flow. Additionally, since this drug contains lactose, individuals with lactose intolerance or related genetic disorders should not take it. Patients with a history of significant liver or kidney impairment should use this drug with caution. As it is primarily metabolized in the liver, liver function may deteriorate, and in cases of kidney dysfunction, the risk of side effects also increases. There may be an increased risk of muscle damage when taken with certain specific medications; thus, patients taking fibrates, immunosuppressants, niacin, certain antibiotics, etc. should exercise caution. Patients who excessively consume alcohol or have severe myasthenia gravis should also be careful, and those with prior muscle issues related to medications of the same class should be particularly cautious. During the use of this drug, side effects such as rash, myalgia, weakness, dyspepsia, liver dysfunction, kidney dysfunction, headache, and dizziness may occur, so if these symptoms arise, immediate medical consultation is required. Especially, muscle-related unusual symptoms can lead to severe kidney damage, so if muscle pain or weakness is severe or accompanied by fever, the patient should visit the hospital immediately. This drug is used in the treatment of hypercholesterolemia, thus before treatment, thorough testing to confirm this condition is necessary, and blood lipid levels should be regularly monitored during treatment to evaluate effectiveness. Pregnant or nursing women should never take this drug, as it may be harmful to the fetus or infant. The elderly may have decreased bodily functions, so dose adjustment and caution are needed. This drug can interact with other medications, so if the patient is taking other drugs, they must inform their healthcare provider and be aware that there may be an increased risk of muscle damage when used in conjunction with certain drugs. In case of overdose, an assessment including liver function tests by a healthcare provider is necessary, and careful observation is required even if there are no unusual symptoms. This drug is more effective when taken after dinner, and when taken alongside antacids or ion exchange resin preparations, it should be spaced out in timing. Finally, it is important to store this drug in a safe place out of reach of children and not to transfer it to another container to maintain its quality.

Side effects

Rash, anaphylaxis, thrombocytopenia, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, vasculitis, lupus-like syndrome, photosensitivity, hypotension, angioedema, dermatomyositis, pruritus, diarrhea, nausea, vomiting, constipation, abdominal pain, upper abdominal discomfort, stomatitis, heartburn, abdominal distension, loss of appetite, liver dysfunction, increased BUN, elevated serum creatinine, myalgia, weakness, elevated CPK, increased myoglobin, rhabdomyolysis, acute renal failure, arthritis, arthralgia, myopathy, headache, dizziness, insomnia, peripheral neuropathy, depression, malaise, fatigue, sleep disturbances, cognitive impairment, elevated uric acid, hematuria, edema, hair loss, erectile dysfunction, pancreatitis, gastritis, granuloma, depigmentation, skin and mucosal dryness, hair and nail changes, taste disturbances, extraocular muscle movement disorders, facial paralysis, tremor, memory loss, peripheral nerve palsy, cataract, ocular muscle paralysis, rheumatoid polymyalgia, urticaria, fever, flushing, weakness, dyspnea, purpura, erythema multiforme, eosinophilia, chills, mucosal skin syndrome, thyroid dysfunction, liver histological changes, cirrhosis, liver cancer, myasthenia gravis, sleep disturbances, amnesia, depression, interstitial lung disease, sexual dysfunction, fatal and non-fatal liver failure, ocular muscle weakness, frequency varies depending on the presence of risk factors, immune-mediated necrotizing myopathy

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Storing it this way will help retain the drug's effectiveness and safety for a long time.

Appearance and packaging

Appearance

It is a reddish-brown oblong tablet.

Package unit

100 tablets/PTP (10 tablets/PTP*10), 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.